Upexi, Inc. (NASDAQ:UPXI) Director Buys $100,000.42 in Stock

Key Points

• Gene Salkind, a director of Upexi, Inc., purchased 20,243 shares of the company’s stock on July 11th for an average cost of $4.94 per share, totaling over $100,000 and increasing his ownership by 5.54%.
• Following the purchase, Upexi's shares fell by 9.9%, trading at $4.89 with a volume exceeding its average.
• Upexi recently reported a quarterly loss of ($2.87) EPS and a revenue of $3.16 million, highlighting a negative net margin of 135.86% and return on equity of 535.19%.

Upexi, Inc. (NASDAQ:UPXI - Get Free Report) Director Gene Salkind bought 20,243 shares of the stock in a transaction dated Friday, July 11th. The shares were purchased at an average cost of $4.94 per share, for a total transaction of $100,000.42. Following the completion of the transaction, the director directly owned 385,370 shares of the company's stock, valued at $1,903,727.80. This trade represents a 5.54% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Upexi Stock Down 0.9%

UPXI traded down $0.04 during trading on Friday, reaching $4.60. 5,516,228 shares of the company were exchanged, compared to its average volume of 12,718,688. The company's 50-day moving average is $7.42 and its two-hundred day moving average is $5.98. The company has a debt-to-equity ratio of 0.31, a quick ratio of 0.24 and a current ratio of 0.37. Upexi, Inc. has a 12-month low of $1.90 and a 12-month high of $22.57.

Upexi (NASDAQ:UPXI - Get Free Report) last issued its quarterly earnings data on Friday, May 16th. The company reported ($2.87) earnings per share (EPS) for the quarter. The company had revenue of $3.16 million for the quarter. Upexi had a negative return on equity of 535.19% and a negative net margin of 135.86%.

Institutional Trading of Upexi

A number of institutional investors have recently added to or reduced their stakes in UPXI. Bank of Montreal Can purchased a new stake in shares of Upexi in the 4th quarter valued at about $36,000. North Star Investment Management Corp. purchased a new stake in shares of Upexi in the 2nd quarter valued at about $45,000. Finally, Kathmere Capital Management LLC purchased a new stake in shares of Upexi in the 2nd quarter valued at about $6,535,000. Hedge funds and other institutional investors own 5.68% of the company's stock.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on UPXI. Wall Street Zen upgraded Upexi to a "hold" rating in a report on Friday, May 30th. Cantor Fitzgerald raised Upexi from a "neutral" rating to an "overweight" rating and set a $16.00 price target on the stock in a research report on Monday, June 16th.

About Upexi

Upexi, Inc manufactures and sells various branded products in the health, wellness, pet, beauty, and other markets. The company was formerly known as Grove, Inc and changed its name to Upexi, Inc in August 2022. The company was incorporated in 2018 and is headquartered in Clearwater, Florida.